<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

CU Cancer Center News and Stories

DOM Newsletter

Research    Colorectal Cancer    Clinical Trials    DOM Newsletter

CU Cancer Center Leading Clinical Trial of New Drug to Treat Metastatic Colorectal Cancer

A new phase 2 clinical trial led by University of Colorado Cancer Center member Robert Lentz, MD, may offer hope for patients with metastatic colon cancer for whom standard therapy is no longer effective. Lentz is mentored by Wells Messersmith, MD, associate director of clinical services at the CU Cancer Center.

Author Greg Glasgow | Publish Date September 07, 2022
Full Story

CU Cancer Center In the News

Health Imaging

New Lesion Measurement Assesses Treatment Responses More Accurately than RECIST

news outletHealth Imaging
Publish DateSeptember 30, 2022

A new way of assessing cancer lesions’ response to treatment could pave the way for developing new cancer therapeutics.

Full Story
Targeted Oncology

Clinical Commentary: Managing Adverse Events From PARP Inhibitors in Advanced Ovarian Cancer

news outletTargeted Oncology
Publish DateSeptember 30, 2022

PARP inhibitors can play a significant role in the first-line setting for patients with advanced ovarian cancer.

Full Story

ODAC Votes Against Safety Profile of Secura Bio’s P13K Inhibitor

news outletBiospace
Publish DateSeptember 26, 2022

In an 8-4 vote, the FDA’s Oncologic Drugs Advisory Committee Roster voted against the benefit-risk profile of Secura Bio’s P13K inhibitor Copiktra.

Full Story
Cancer Health

Abortion Ban Will Harm Women Diagnosed with Breast Cancer During Pregnancy

news outletCancer Health
Publish DateSeptember 22, 2022

Two CU Cancer Center members detail how the Supreme Court decision in Dobbs V. Jackson Women’s Health Organization will harm some patients.

Full Story